Menthol

Menthol

SCHEMBL318442

CC1CCC(C(C)C)C(O)C1.CCOCC.OCC(O)CO

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TRPA1TRPM8

The experimentally established mechanism targets of Menthol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 known ✓ Q7Z2W7 3/20 0.62
TRPA1 known ✓ O75762 2/20 0.62
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.37
EPHX1 P07099 3/20 0.36
KDM4E B2RXH2 1/20 0.36
APOBEC3A P31941 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NTSR1 P30989 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
OPRM1 P35372 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
XBP1 P17861 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Menthol SCHEMBL1617429 0.91 TRPM8 (0.75) TRPM8TRPA1LMNAMAPTEPHX1
Menthol SCHEMBL3378958 0.91 TRPM8 (0.75) TRPM8TRPA1LMNAMAPTEPHX1
Menthol SCHEMBL18787982 0.90 TRPM8 (0.60) TRPM8TRPA1LMNAMAPTEPHX1
Menthol SCHEMBL119538 0.87 TRPM8 (0.64) TRPM8TRPA1LMNAMAPTEPHX1
Menthol SCHEMBL2634088 0.85 TRPM8 (0.66) TRPM8TRPA1LMNAMAPTEPHX1
Menthol SCHEMBL2311281 0.82 TRPM8 (0.78) TRPM8TRPA1LMNAEPHX1KDM4E
Menthol SCHEMBL28157641 0.82 TRPM8 (0.84) TRPM8TRPA1LMNAEPHX1KDM4E
Levomenthol SCHEMBL22227514 0.82 TRPM8 (0.84) TRPM8TRPA1LMNAEPHX1KDM4E
Menthol SCHEMBL4086460 0.82 TRPM8 (0.84) TRPM8TRPA1LMNAEPHX1KDM4E
Menthol SCHEMBL28482985 0.81 TRPM8 (0.60) TRPM8TRPA1LMNAMAPTEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190037896-A1 COOLING FORMULATIONS WM. WRIGLEY JR. COMPANY (US) 2019-02-07 US claimed
EP-3355710-A2 COOLING FORMULATIONS Wm. Wrigley Jr. Company (US) 2018-08-08 EP claimed
US-7025999-B2 Chewing gum having prolonged sensory benefits WM. WRIGLEY JR. COMPANY (US) 2006-04-11 US claimed
US-20050202118-A1 Chewing gum products containing trigeminal stimulant and method of making the same WM. WRIGLEY JR. COMPANY 2005-09-15 US claimed
US-20030072842-A1 Chewing gum having prolonged sensory benefits WM. WRIGLEY JR. COMPANY 2003-04-17 US claimed
WO-2002091849-A1 A CHEWING GUM HAVING PROLONGED SENSORY BENEFITS WM. WRIGLEY JR. COMPANY (US) 2002-11-21 WO claimed
WO-2024102626-A1 PRODUCTION OF NATURAL GUM BASE INGREDIENTS BY PLANT CELL FERMENTATION AND APPLICATION THEREOF IN CONFECTIONERY WM. WRIGLEY JR. COMPANY (US) 2024-05-16 WO disclosed
CN-117447748-B Anti-aging ice-fire condom and preparation method thereof 广州双一乳胶制品有限公司 2024-03-29 CN disclosed
US-11930830-B2 System and method of forming multilayer confectionery INTERCONTINENTAL GREAT BRANDS LLC (US) 2024-03-19 US disclosed
CN-117447748-A Anti-aging ice-fire condom and preparation method thereof 广州双一乳胶制品有限公司 2024-01-26 CN disclosed
CN-117440760-A Chewing gum composition beneficial to skin WM.雷格利 JR.公司 2024-01-23 CN disclosed
EP-4304372-A1 CHEWING GUM COMPOSITIONS FOR SKIN BENEFITS WM. Wrigley Jr. Company (US) 2024-01-17 EP disclosed
US-20230329277-A1 CANDY WITH VISUAL EFFECTS AND PRODUCTION METHODS THEREOF BABIN KATHERINE DEJARNETTE (US) 2023-10-19 US disclosed
WO-2006127605-A2 CONFECTIONERY COMPOSITION INCLUDING AN ELASTOMERIC COMPONENT, A COOKED SACCHARIDE COMPONENT, AND A SWEETENER CADBURY ADAMS USA LLC (US) 2006-11-30 WO disclosed
US-20060263476-A1 Center-filled chewing gum with barrier layer CADBURY ADAMS USA, LLC. 2006-11-23 US disclosed
US-20060263475-A1 Center-filled chewing gum composition CADBURY ADAMS USA, LLC. 2006-11-23 US disclosed
US-7025999-B2 Chewing gum having prolonged sensory benefits WM. WRIGLEY JR. COMPANY (US) 2006-04-11 US disclosed
US-20050202118-A1 Chewing gum products containing trigeminal stimulant and method of making the same WM. WRIGLEY JR. COMPANY 2005-09-15 US disclosed
US-20030072842-A1 Chewing gum having prolonged sensory benefits WM. WRIGLEY JR. COMPANY 2003-04-17 US disclosed
WO-2002091849-A1 A CHEWING GUM HAVING PROLONGED SENSORY BENEFITS WM. WRIGLEY JR. COMPANY (US) 2002-11-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190037896-A1 COOLING FORMULATIONS TAS2R30, MGLL, TAS2R60 TRPM8 83/4885TRPA1 305/4885LMNA 2069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.